TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $392,750 | -81.5% | 25,000 | -80.6% | 0.00% | -75.0% |
| Q1 2023 | $2,127,568 | -81.5% | 129,100 | -85.4% | 0.00% | -77.8% |
| Q3 2022 | $11,472,000 | +1659.5% | 884,500 | +2122.4% | 0.02% | – |
| Q3 2021 | $652,000 | +9214.3% | 39,800 | +9850.0% | 0.00% | – |
| Q2 2019 | $7,000 | -99.7% | 400 | -99.6% | 0.00% | -100.0% |
| Q1 2019 | $2,231,000 | – | 109,546 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |